QIAGEN N.V. QGEN

Company Overview

QIAGEN N.V. is a global provider of sample and assay technologies used in molecular diagnostics, applied testing, academic research, and pharmaceutical development. The company operates primarily in the life sciences and healthcare industries, focusing on technologies that enable the isolation, processing, and analysis of DNA, RNA, and proteins from biological samples. QIAGEN’s core offerings support clinical testing, infectious disease detection, oncology profiling, companion diagnostics, and genomic research. Its revenue base is diversified across consumables, instrumentation, bioinformatics, and diagnostic solutions, with recurring revenue driven heavily by consumable products and testing workflows.

The company was founded in 1984 in Germany and later established its holding structure in the Netherlands. Over time, QIAGEN expanded from sample preparation technologies into molecular diagnostics, sequencing support, and digital bioinformatics through acquisitions and internal development. Its strategic positioning is built around integrated “Sample to Insight” workflows, combining extraction technologies, PCR and sequencing solutions, and data interpretation software. QIAGEN has developed a significant presence in precision medicine and infectious disease testing markets, supported by relationships with healthcare systems, research institutions, and pharmaceutical companies.